Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@leevalueroach 3 clicks

Lee Roach on X

Rayonier $RYN owns 4,003,000 acres across eleven states. Here's what happens when you value everything else on the balance sheet and subtract it. Enterprise value is $7.64B. Market cap $6.19B plus $1.45B of net debt. Now take out the pieces that aren't dirt: Six sawmills and a plywood mill, $1.0B. Cross-checked two ways. Replacement cost runs ~$700/MBF on 1,155 MMBF of capacity. Mid-cycle EBITDA of $175M at 6x gets you the same place. Three master-planned communities, $482M. Wildlight north of Jacksonville, Heartwood next to Hyundai's $7.59B plant in Georgia, Chenal Valley in Little Rock at 70% sold out. DCF'd at 12%. The rural land program, $650M. They sold 7,490 acres at $5,439 last quarter against a portfolio the market marks at $1,447. That 3.7x spread on ~30,000 acres a year, decayed and discounted over a 13-year runway. Solar options on 77,000 acres, $125M at a 25% conversion assumption. Carbon storage across 154,000 acres, $80M. Smackover lithium, $30M. Real geology, ten cents a share. The below-market debt mark, $130M, audited on the balance sheet. That leaves $5.14B for the timberland. Now subtract the trees. 188M tons of standing merchantable inventory at current TimberMart-South stumpage, with pine sawtimber at $23.34/ton and pulpwood at $5.40, is $3.57B. Residual: $1.57B of bare land across 4,003,000 acres. $393 an acre. Cutover land in the South, meaning ground that was just harvested with zero merchantable timber on it, transacts between $1,200 and $1,800. Three marks you can check yourself: In August the company sold 36,000 Washington acres at $4,028 and bought 57,000 Texas and Alabama acres at $2,561. Same month, same management. They paid 77% more than the market credits them for what they already own. Morgan Stanley's fairness opinion produced $47.55 to $55.80 on a DCF and $20.85 to $25.20 on trading comps in the same document. The stock is at $20.81. That gap is institutional cost of capital at 7% versus public equity demanding 9 to 10%, applied to an asset with thirty-year cash flows. Management bought back 4.9M shares for $103.5M in H1 and repaid a $200M term loan with cash rather than refinance it. I built the whole thing a second way, from transaction comps by state instead of tons and dirt. $31.80 versus $31.66. Bear case marks the entire South at $1,700/acre, puts the mills at a trough multiple, converts solar at 15%, and still lands at $24.74. Every case sits above the current price. One caveat I'll state myself: the $393 assumes rural HBU is a separate asset. Treat it as embedded in land value instead and you get $555. Still under cutover. The conclusion holds either way. Full work, every input shown, plus the part about the debt structure that I think almost nobody is modeling, linked below.
@ACapitalLP 1 click

A Capital on X

The best trades are where perception <> reality. A common trader exercise is to ask yourself: who is on the other side of the trade and why are they selling to you? What information do they have? Are they more informed than you? The best opportunities are where the seller isn’t more informed, they’re simply misinformed about what’s actually going on. Take $OWL, where the prevailing narrative was a private credit apocalypse, but you did the work and saw the residual value in the fund stakes business and an overblown level of negative sentiment. Or $TLN, where Governor Josh Shapiro and CNN want you to believe data centers are the problem, while the thirst for compute, contractual cash flows and need for electricity remain undeniable. The narrative may work against you initially. That’s often what creates the opportunity. But if your work is thorough enough, your thesis is right and you can hang in there, the gap between perception and reality eventually closes. That’s where alpha is made.

Investor Letters

All letters

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 6 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 5 clicks

Coupang: 3Q26 Business Recap

Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…

CPNG $27B
Speedwell Memos 3 clicks

update on Gartner

Gartner’s growth has stalled after federal contract losses and cautious commercial spending, raising questions about its competitive…

IT $13B
scuttleblurb 1 click

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.